Screening of potential biomarkers for drug-induced liver injury based on HP-CIL LC-MS metabolomics technology

Wei Xianni, Wei Jinbao, Xie Genying, Liu Jie, Wu Wenjing, Lian Siheng

PDF(2898 KB)
PDF(2898 KB)
Adverse Drug Reactions Journal ›› 2026, Vol. 28 ›› Issue (2) : 87-94. DOI: 10.3760/cma.j.cn114015-20250429-00234-1

Screening of potential biomarkers for drug-induced liver injury based on HP-CIL LC-MS metabolomics technology

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 28(2): 87-94 https://doi.org/10.3760/cma.j.cn114015-20250429-00234-1

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2898 KB)

Accesses

Citation

Detail

Sections
Recommended

/